-- Shire considering bid for NPS Pharmaceuticals - FT
-- 
-- Fri May 30, 2014 11:03AM EDT
-- None



LONDON, May 30 (Reuters) - London-listed drugmaker Shire <SHP.L> is considering a bid for New Jersey-based NPS Pharmaceuticals <NPSP.O>, FT Alphaville reported on Friday citing sources.

Shire has been working with advisers and held internal discussions about a potential cash offer for NPS, a rare disease specialist, valuing the business at just over $4 billion, the Financial Times blog said.  Shares in Nasdaq-listed NPS were trading 15.5 percent higher at 1500 GMT giving the company a market capitalisation of $2.92 billion. Shares in Shire were trading down 1.4 percent.